Questions about peptides? Click here to schedule a free consultation with a physician.
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist that has been extensively investigated within the fields of neuroendocrinology, receptor pharmacology, and peptide signaling research. Derived from melanocortin peptide analogues, PT-141 has attracted scientific interest due to its interaction with melanocortin receptor systems involved in neurological and physiological regulation.
Researchers have studied PT-141 as a tool for examining melanocortin signaling pathways, central nervous system activity, neuroendocrine communication, and receptor-mediated physiological responses. Its unique mechanism of action has made it a valuable compound for investigating the broader role of melanocortin receptors in biological function.
For laboratory research and analytical purposes only. Not intended for human consumption, therapeutic use, or clinical application.
PT-141 Chemical Makeup
Molecular formula: C50H68N14O10
Molecular weight: 1025.18 g/mol
Other Known Titles: Bremelanotide
Product Overview
PT-141 is a synthetic peptide analogue designed to interact with melanocortin receptor pathways. Unlike naturally occurring melanocortin peptides, PT-141 was developed to provide enhanced receptor activity and stability for research applications.
Scientific investigations have explored its effects on central melanocortin signaling networks and receptor-mediated physiological processes.
Current areas of scientific interest include:
- Melanocortin receptor research
- Neuroendocrine signaling studies
- Central nervous system investigations
- Receptor pharmacology research
- Peptide signaling pathway analysis
- Neurobiological regulation studies
- Hormonal communication research
Due to its distinct receptor-targeting properties, PT-141 remains an important compound within peptide and neuroendocrine research.
Technical Specifications
| Parameter | Specification |
| Product Name | PT-141 |
| Alternative Name | Bremelanotide |
| Peptide Class | Melanocortin Receptor Agonist |
| Molecular Type | Synthetic Peptide |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.2 g/mol |
| Purity | Research Grade |
| Appearance | Lyophilized Powder |
| Solubility | Suitable for laboratory reconstitution |
| Storage Conditions | Store according to product documentation |
| Intended Use | Research and Laboratory Applications Only |
Scientific Background
PT-141 was developed from research involving melanocortin peptides, a family of signaling molecules known to participate in a variety of physiological and neurological processes.
The melanocortin receptor system plays a role in numerous biological functions, including neuroendocrine regulation, energy balance, pigmentation pathways, and central nervous system signaling. Researchers have utilized PT-141 to better understand the activity of specific melanocortin receptor subtypes and their downstream physiological effects.
Its receptor selectivity and well-characterized pharmacological profile have contributed to its widespread use in experimental studies.
Research Applications
Melanocortin Receptor Studies
One of the primary areas of investigation involving PT-141 centers on melanocortin receptor biology.
Researchers have examined how activation of melanocortin receptors influences intracellular signaling pathways, receptor regulation, and physiological responses. These studies continue to improve understanding of receptor-mediated communication within complex biological systems.
This remains one of the most established applications of PT-141 research.
Neuroendocrine Signaling Research
The nervous and endocrine systems rely on intricate signaling networks to coordinate physiological responses.
Experimental investigations have explored how PT-141 interacts with neuroendocrine pathways and receptor systems involved in hormonal communication. Researchers continue to evaluate these mechanisms to better understand the relationship between neurological signaling and endocrine regulation.
These findings contribute to the broader field of neuroendocrinology.
Central Nervous System Investigations
PT-141 has been widely studied for its interaction with central nervous system signaling pathways.
Researchers have utilized the peptide to examine receptor activity within neural circuits and to investigate how melanocortin pathways influence neurological communication. These studies continue to provide valuable insights into the biological roles of melanocortin receptors.
This area remains a major focus of ongoing scientific research.
Receptor Pharmacology Studies
The peptide’s receptor selectivity has made it a valuable research tool for pharmacological investigations.
Scientists have studied PT-141 to better understand ligand-receptor interactions, receptor activation mechanisms, and downstream signaling events associated with melanocortin receptor agonism.
Such investigations continue to advance knowledge of peptide-based receptor pharmacology.
Peptide Signaling Research
Peptide signaling molecules play critical roles in cellular communication and physiological regulation.
Researchers have examined PT-141 within experimental models designed to explore how peptide-receptor interactions influence biological signaling networks. These studies contribute to a deeper understanding of molecular communication systems throughout the body.
Further research remains ongoing in this area.
Hormonal Communication Studies
Melanocortin signaling pathways are interconnected with multiple endocrine and neurochemical systems.
Scientific investigations have explored how PT-141 may influence communication between regulatory pathways involved in maintaining physiological balance. Researchers continue to study these interactions to better characterize complex signaling relationships within biological systems.
This remains an active area of research interest.
Mechanisms Under Investigation
Current scientific literature suggests that PT-141 may exert biological activity through mechanisms that include:
- Activation of melanocortin receptor pathways
- Modulation of neuroendocrine signaling systems
- Participation in central nervous system communication
- Influence on receptor-mediated cellular responses
- Interaction with peptide signaling networks
- Regulation of downstream intracellular signaling pathways
Many aspects of these mechanisms remain active areas of research and continue to be explored in experimental settings.
Research Significance
PT-141 represents an important advancement in melanocortin receptor research due to its selective receptor activity and well-defined pharmacological profile.
Its use in studies involving receptor biology, neuroendocrine regulation, and peptide signaling has contributed significantly to scientific understanding of melanocortin-mediated physiological processes.
As peptide-based receptor research continues to expand, PT-141 remains a widely studied compound within academic, commercial, and laboratory research environments.
Quality and Research Standards
Our research-grade PT-141 is manufactured under strict quality-control procedures designed to support consistency, purity, and reliability for laboratory applications.
Each production batch undergoes analytical testing to help ensure product integrity and suitability for scientific investigation.
Researchers should follow all established laboratory handling, storage, and safety protocols when working with peptide materials.
Important Notice
This product is supplied exclusively for:
- Scientific research
- Laboratory investigation
- Analytical testing
- Educational applications
This material is not intended for:
- Human consumption
- Veterinary administration
- Medical treatment
- Diagnostic use
- Therapeutic application
Users are responsible for complying with all applicable regulations and institutional requirements concerning the purchase, handling, storage, and use of research compounds.
References
PT-141 has been the subject of scientific investigation in the fields of neuroendocrinology, receptor pharmacology, peptide signaling, neuroscience, melanocortin biology, and endocrine research. Researchers are encouraged to consult peer-reviewed literature and experimental studies for detailed methodologies and findings relating to this peptide.
Authoritative Sources
These sources provide further information in relation to peer reviewed research and findings.
- Official FDA bremelanotide label
- PubMed PT-141 pharmacology summary
- Mayo Clinic bremelanotide overview
This content is for informational purposes only and is not a substitute for professional medical advice.
Research & Education Tool
PT-141 Dosage Calculator
Enter the vial amount, diluent volume, syringe size, and target amount to estimate concentration, draw volume, and approximate vial yield.
For research and educational use only. Check all values against the product label, certificate of analysis, and any applicable professional guidance before relying on the result.
mg
Draw Reference
Enter values to estimate the syringe mark.
Express Shipping - from $29.99
Shipping with this method takes 3-5 days
Prices:
- Dry-Packed Products $29.99
- Cold-Packed Products $39.99
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $19.99
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $19.99
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
What does the PT-141 peptide do?
PT-141, also associated with bremelanotide, acts on melanocortin receptors involved in sexual desire pathways. It is different from medicines that mainly improve blood flow. Official bremelanotide labeling focuses on acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. It is not a universal libido treatment, testosterone booster, or recreational enhancer.
Is PT-141 the same as bremelanotide?
PT-141 is the development name commonly linked with bremelanotide. Bremelanotide is the generic drug name used in official labeling for the approved subcutaneous injection. Online listings, clinic materials, and peptide discussions may use the terms differently, so the exact route, concentration, presentation, and instructions on the product listing matter.
Is PT-141 better than Viagra?
It is not best understood as better or worse than Viagra. Bremelanotide is discussed for sexual desire pathways, while Viagra is used for erectile dysfunction through blood-flow effects. The right comparison depends on the symptom being treated, medical history, other medicines, and clinician assessment. Desire concerns and erection concerns may need different approaches.
What safety issues should I discuss before using it?
Discuss blood pressure history, heart disease, nausea risk, pregnancy or breastfeeding, skin darkening, and injection reactions. Bremelanotide labeling warns about temporary blood pressure increases and heart rate decreases, and it is contraindicated with uncontrolled hypertension or known cardiovascular disease. A clinician should also review other medicines, especially oral naltrexone and cardiovascular drugs.
What should I ask my clinician before selecting a form?
Ask which route is intended, what strength or concentration applies, how the product should be stored, what side effects to watch for, and whether any current medicines create interaction concerns. If comparing injection and nasal presentations, ask whether they are clinically appropriate alternatives or completely separate options. Do not change form or frequency without clinical direction.
Rewards Program
Earn points on birthdays, product orders, reviews, friend referrals, and more! Enjoy your medication at unparalleled discounts while reaping rewards for every step you take with us.
You can read more about rewards here.
POINT VALUE
How to earn points
- 1Create an account and start earning.
- 2Earn points every time you shop or perform certain actions.
- 3Redeem points for exclusive discounts.
